Youth opioid overdoses have risen since the pandemic, according to a study analyzing nationwide EMS encounters recently published in JAMA.
Faculty, staff, trainees and students came together to share educational research and best teaching practices during Feinberg’s 14th annual Medical Education Day on October 15.
Northwestern Medicine scientists have discovered how a protein in a deadly type of lung cancer can control how the immune system responds to the tumor, according to a study published in the Proceedings of the National Academy of Sciences.
The average length of survival for glioblastoma has failed to improve since it was first identified in scientific literature nearly 100 years ago. Despite this, scientists at Feinberg remain steadfast in their commitment to improving the understanding and treatment of glioblastoma through rigorous research initiatives and clinical trials.
People assigned male at birth who belong to a sexual or gender minority group are twice as likely to use methamphetamine following an HIV diagnosis, according to a study published in the Proceedings of the National Academy of Sciences.
Stephen Freeman, a fourth-year MD/MPH student at Feinberg, has been selected to participate in the Pisacano Scholars Leadership Program, a highly competitive professional development and scholarship opportunity given to exceptional future leaders in family medicine.
Northwestern Medicine investigators have created a novel blood test that identifies adults who may be at increased risk of developing severe respiratory illnesses, according to a recent study published in the American Journal of Respiratory and Critical Care Medicine.
Feinberg students, faculty, trainees and staff gathered in a packed Hughes Auditorium for the Office of Diversity and Inclusion’s annual Fall Lyceum on October 8.
Northwestern Medicine investigators have discovered that a novel combination treatment promotes cancer cell death and tumor regression in mouse models of pancreatic cancer, providing a rationale for testing in future clinical trials, according to recent findings.
Investigators have discovered that targeting specific mechanisms linked to lipid metabolism in immune cells within tumors may improve response to current and future cancer immunotherapies, according to a recent study published in the journal Immunity.